CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
CareDx (CDNA) Tops Q3 EPS by 39c, Beats on Revenue; Offers FY24 Revenue Guidance
November 4, 2024 4:27 PM ESTCareDx (NASDAQ: CDNA) reported Q3 EPS of $0.14, $0.39 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $82.9 million versus the consensus estimate of $79.69 million.
GUIDANCE:
CareDx sees FY2024 revenue of $327-331 million, versus the consensus of $326... More
